Clinical Trial Update: JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo [Phase 3]

View source ↗

Summary

Phase 3 trial of the JYNNEOS smallpox vaccine in adult healthcare personnel at risk for mpox in the Democratic Republic of the Congo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• JYNNEOS (Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN))

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Monkeypox Virus Infection | Phase 3 | Status: COMPLETED